Citation 75162

MURAKAMI,A: NAKAMURA,Y: KOSHIMIZU,K: OHIGASHI,H:. (1995). GLYCEROGLYCOLIPIDS FROM CITRUS HYSTRIX, A TRADITIONAL HERB IN THAILAND, POTENTLY INHIBIT THE TUMOR-PROMOTING ACTIVITY OF 12-O-TETRADECANOYLPHORBOL 13-ACETATE IN MOUSE SKIN.. 43(10)

Citation Details

Title	GLYCEROGLYCOLIPIDS FROM CITRUS HYSTRIX, A TRADITIONAL HERB IN THAILAND, POTENTLY INHIBIT THE TUMOR-PROMOTING ACTIVITY OF 12-O-TETRADECANOYLPHORBOL 13-ACETATE IN MOUSE SKIN.
Authors	MURAKAMI,A: NAKAMURA,Y: KOSHIMIZU,K: OHIGASHI,H:
Year	1995
Volume	43
Issue	10

Summary

Year: 1995

Journal: Unknown

Organisms and Their Experiments (2)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	EARLY ANTIGEN VIRAL INDUCTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CAROTENE,BETA:	ACTIVE
2	EARLY ANTIGEN VIRAL INDUCTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GALLOCATECHIN-3-O-GALLATE,EPI: (-):	ACTIVE
3	ANTITUMOR-PROMOTING ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	GALLOCATECHIN-3-O-GALLATE,EPI: (-):	ACTIVE
4	ANTIINFLAMMATORY ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	GALLOCATECHIN-3-O-GALLATE,EPI: (-):	ACTIVE
5	EARLY ANTIGEN VIRAL INDUCTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LINOLENIC ACID,ALPHA:	ACTIVE
6	ANTITUMOR-PROMOTING ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	LINOLENIC ACID,ALPHA:	ACTIVE

Citrus hystrix (RUTACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	GLYCEROL,SN: 1-2-DI-O-ALPHA-LINOLENOYL-3-O-BETA-GALACTOPYRANOSYL:	None
2	EARLY ANTIGEN VIRAL INDUCTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GLYCEROL,SN: 1-2-DI-O-ALPHA-LINOLENOYL-3-O-BETA-GALACTOPYRANOSYL:	ACTIVE
3	ANTITUMOR-PROMOTING ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	GLYCEROL,SN: 1-2-DI-O-ALPHA-LINOLENOYL-3-O-BETA-GALACTOPYRANOSYL:	ACTIVE
4	ANTIINFLAMMATORY ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	GLYCEROL,SN: 1-2-DI-O-ALPHA-LINOLENOYL-3-O-BETA-GALACTOPYRANOSYL:	ACTIVE
5	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	GLYCEROL,SN: 1-O-ALPHA-L-LINOLENOYL-2-O-PALMITOYL-3-O-BETA-D-GALACTOPYRANOSYL:	None
6	EARLY ANTIGEN VIRAL INDUCTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GLYCEROL,SN: 1-O-ALPHA-L-LINOLENOYL-2-O-PALMITOYL-3-O-BETA-D-GALACTOPYRANOSYL:	ACTIVE
7	ANTIINFLAMMATORY ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	GLYCEROL,SN: 1-O-ALPHA-L-LINOLENOYL-2-O-PALMITOYL-3-O-BETA-D-GALACTOPYRANOSYL:	ACTIVE
8	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	GLYCEROL,SN: 1-O-PALMITOYL-2-O-ALPHA-L-LINOLENOYL-3-O-BETA-D-GALACTOPYRANOSYL:	None
9	EARLY ANTIGEN VIRAL INDUCTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GLYCEROL,SN: 1-O-PALMITOYL-2-O-ALPHA-L-LINOLENOYL-3-O-BETA-D-GALACTOPYRANOSYL:	ACTIVE
10	ANTIINFLAMMATORY ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	GLYCEROL,SN: 1-O-PALMITOYL-2-O-ALPHA-L-LINOLENOYL-3-O-BETA-D-GALACTOPYRANOSYL:	ACTIVE